An Absorbable Suture Versus a Non-absorbable Suture in Carpal Tunnel Release, a Randomized Controlled Trial
Launched by KUOPIO UNIVERSITY HOSPITAL · Aug 15, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of stitches used to close the wound after surgery for carpal tunnel syndrome, a condition that causes pain and numbness in the hand due to pressure on the median nerve. The trial aims to find out whether absorbable stitches, which dissolve over time, are better than non-absorbable stitches, which need to be removed later. Participants will be randomly assigned to one of the two groups, and the appearance of their scars will be evaluated one year after their surgery.
To be eligible for this trial, participants must be diagnosed with carpal tunnel syndrome and have typical symptoms of the condition. They should also be scheduled for carpal tunnel release surgery and be able to understand and respond to questions sent via email. However, individuals who have had previous surgery on the same wrist, have certain allergies, or are currently undergoing specific medical treatments may not be eligible. If you decide to participate, you can expect to help researchers learn more about which type of suture is better for healing, contributing valuable information that could benefit future patients.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria
- • carpal tunnel syndrome diagnosed with electro near my-graphs
- • symptoms typical of carpal tunnel syndrome
- • referral to carpal tunnel release
- • informed consent signed
- • the ability to receive the virtual questionnaire via email and answer it
- • the ability to understand and answer the Finnish questionnaires
- • Exclusion Criteria
- • repeat surgery
- • known allergy to suture materials
- • ongoing systemic steroid treatment
- • ongoing chemotherapy
- • ongoing immunomodulatory treatment
- • past hypertrophic or keloid scars or other severe disturbances in wound healing
- • age under 18, pregnancy or breastfeeding
About Kuopio University Hospital
Kuopio University Hospital is a leading academic medical center located in Finland, dedicated to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient-centered care, focusing on diverse therapeutic areas. With a commitment to enhancing treatment outcomes and improving patient quality of life, Kuopio University Hospital fosters collaboration among multidisciplinary teams, leveraging its robust infrastructure and expertise to drive medical progress and translate research findings into practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kuopio, Pohjois Savo, Finland
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials